Swiss drugmaker Novartis AG (NVS) said Thursday that a study published in the latest issue of ...
Two small midstage studies of an experimental therapy being developed by Avant ...
Sanofi-Aventis SA's (SNY) anti-obesity pill Acomplia has been linked to five deaths and 720 ...
Recently released data is prompting the revision of a large study comparing the use of Imclone ...
Swiss drugmaker Novartis AG (NVS) said Thursday it will continue with trials for its oral ...
A late-stage study of saxagliptin, developed by Bristol-Myers Squibb Co. (BMY) and AstraZeneca ...
A Food and Drug Administration panel didn't recommend approving expanded use of Cephalon Inc.'s ...
Swiss drugmaker Roche Holding AG (RHHBY) said Friday that Actemra can significantly inhibit ...
Sanofi-Aventis SA and Bristol-Myers Squibb Co. are facing possible generic competition in Europe ...
GlaxoSmithKline PLC (GSK) said Monday it is starting a late-stage clinical trial that will study ...
Amgen Inc. (AMGN) said its two-year Phase III study showed that twice-yearly injections of its ...
Schering-Plough Corp. announced a plan to cut costs by $1.5 billion by 2012, after a panel of ...
A trio of papers published Wednesday identifies for the first time a specific genetic variation ...
The Food and Drug Administration requested additional information from Johnson & Johnson and ...
Cephalon Inc. is hoping its move into the lucrative cancer market gets a boost this week with a ...
As pharmaceutical makers find it increasingly difficult to bring new drugs to market, they are ...
Swiss drugmaker Roche Holding AG (RHHBY) said Tuesday that new data from a phase III study on ...
Treatment with Novartis AG's (NVS) Femara can halve the risk of breast cancer returning even when ...
Eli Lilly and Co. is becoming the latest drug maker to abandon the once-promising concept of ...
The Food and Drug Administration wants to allow drug companies to give doctors information about ...
UCB (Euronext: UCB) and sanofi-aventis announced today that the U.S. Food and Drug Administration ...
Genentech Inc. has been waging an uphill fight to add breast-cancer treatment to the approved ...
Patients treated for heart attack or angina and given the anticlotting drug Plavix had a sharply ...
Genentech Inc. said a study showed that its cancer drug Avastin slowed the growth of ...
Cancer cells in the lymph nodes of patients with pancreatic cancer appear to produce enough of a ...
Swiss drug maker Novartis AG said its Menveo vaccine promises to be effective in protecting ...
The effectiveness of a dozen popular antidepressants has been exaggerated by selective ...
German pharmaceutical and chemicals company Bayer AG (BAY.XE) Thursday said it received approval ...
Genentech Inc.'s discovery of two new genes linked to lupus raised hopes of earlier diagnosis ...
A troubling study from Belgium hints that long-term use of oral contraceptives - at least the ...
Merck KGaA said Thursday its division Merck Serono submitted an application to the European ...
AstraZeneca PLC (AZN) Friday said its cholesterol-lowering drug Crestor has been approved in the ...
The Food and Drug Administration said Friday it's approved Zyrtec-D, an allergy drug, as an ...
Abbott Laboratories (ABT) received Food and Drug Administration approval for a new ...
The European Patent Office said Thursday said that it is revoking a patent for AstraZeneca PLC's ...
The Food and Drug Administration said Thursday it expanded the approved age range for Menactra, ...
A Food and Drug Administration panel of outside medical experts is weighing whether ...
Aastrom Biosciences Inc. (ASTM) said results of a Phase I/II clinical trial showed that ...
The U.S. Food and Drug Administration said Thursday it's approved new erectile dysfunction drug ...
Swiss pharmaceutical company Actelion Ltd (ATLN.VX) said Friday that the European Committee for ...
Medical-device maker Medtronic Inc. (MDT) is suspending sales of an electrical wire that ...
The Food and Drug Administration approved Doribax as a new treatment for complicated ...
The U.S. Food and Drug Administration Friday approved a new type of HIV drug from Merck & ...
German pharmaceutical and chemicals company Bayer AG (BAY.XE) Monday said its new multiple ...
Genentech Inc. said it will stop making its cancer drug Avastin available to certain pharmacies ...
Bioxell SpA's (BXLN.EB) share price Friday spiked 7.8% after the Italian biopharmaceutical ...
Teva Pharmaceutical Industries Ltd. (TEVA) said Friday that data from a 16-year follow-up study ...
NPS Pharmaceuticals Inc.'s (NPSP) disappointing trial data may do more than shave off a quarter ...